COVID-19—a trigger factor for severe immune-mediated thrombocytopenia in active rheumatoid arthritis

A Bobircă, F Bobircă, I Ancuța, A Florescu, M Bojincă… - Life, 2022 - mdpi.com
Thrombocytopenia is defined as a platelet count below 150,000/mm3 for adults. There is still
controversy about whether individuals with platelet counts of 100,000/mm3 to 150,000/mm3 …

Dysregulated platelet function in COVID-19 patients

NR Gashimova, VO Bitsadze… - Obstetrics, Gynecology …, 2023 - gynecology.su
More than two year-experience in monitoring patients with severe novel coronavirus disease
revealed an increased risk of macroand microcirculatory thrombosis, clinically manifested by …

[PDF][PDF] Antiplatelet adequacy of cyclopentyl triazolopyrimidine versus clopidogrel in-patients with coronary heart disease

FH Rada - Asian J. Pharm. Clin. Res, 2018 - pdfs.semanticscholar.org
Objective: Ticagrelor, cyclopentyl triazolopyrimidine drug, and Clopidogrel, second-
generation thienopyridine drug are antiplatelet drugs indicated for the prevention of …

[HTML][HTML] Дисрегуляция функции тромбоцитов у больных COVID-19

НР Гашимова, ВО Бицадзе… - Акушерство …, 2022 - cyberleninka.ru
Более чем двухлетний опыт наблюдений за пациентами с тяжелой коронавирусной
болезнью показал повышенный риск тромбозов макро-и микроциркуляторного русла …

[PDF][PDF] EVALUATION OF IN VIVO IMMUNOMODULATORY ACTIVITY OF AQUEOUS AND ETHANOLIC EXTRACT OF EULOPHIA NUDA L.

V Kanase, DT PATIL - EVALUATION, 2018 - academia.edu
Objective: The aim of this study was to evaluate the in vivo immunomodulatory activity of an
aqueous and ethanolic extract of dried tubers of Eulophia nuda (ENA and ENE). Methods …

Studying activity and toxicity of different TNF-alpha inhibitors in controlling patients with active ulcerative colitis

BAR Mshimesh - Journal of Applied Pharmaceutical Science, 2019 - japsonline.com
Ulcerative colitis (UC) is a long-term disorder that associated with overactivation of
immunoinflammatory system, ending with ulcer in the large intestine. This study aimed to …

[PDF][PDF] Efficacy and safety of adalimumab versus infliximab in patients suffered from moderate to severe active ulcerative colitis

BR Mshimesh - Asian J Pharm Clin Res, 2017 - pdfs.semanticscholar.org
Objective: Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease of the large
intestine, usually involving the rectum. During the last decade, clinical trials have shown …

[PDF][PDF] Role of antioxidant and myeloperoxidase levels in 7, 12-dimethylbenz [a] anthracene induced experimental rat model: Evidence for oxidative damage in active …

P Geetha, BL Kumar, U Indra, P Sheetal - Int J Pharm Pharm Sci, 2017 - academia.edu
Objective: Ulcerative colitis known as inflammatory bowel disease (IBD) of unknown
etiology. We examined the antioxidant and myeloperoxidase status in a murine model of 7 …

[引用][C] Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab.

L Del Olmo Martínez - Gastroenterologia y Hepatologia, 2019 - europepmc.org
Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic
treatment with adalimumab. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[引用][C] Púrpura trombocitopénica inmune asociada a colitis ulcerosa inactiva en tratamiento crónico con adalimumab

B Velayos Jiménez, R Cuello García… - … . hepatol.(Ed. impr.), 2020 - pesquisa.bvsalud.org
Púrpura trombocitopénica inmune asociada a colitis ulcerosa inactiva en tratamiento
crónico con adalimumab | Gastroenterol. hepatol. (Ed. impr.);43(1): 28-29, ene. 2020 …